News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,952 Results
Type
Article (13811)
Company Profile (101)
Press Release (252040)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88090)
Career Advice (465)
Deals (15346)
Drug Delivery (67)
Drug Development (36630)
Employer Resources (49)
FDA (6299)
Job Trends (6203)
News (150311)
Policy (14051)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (443)
Accelerated approval (2)
Adcomms (6)
Allergies (33)
Alliances (23241)
ALS (36)
Alzheimer's disease (393)
Antibody-drug conjugate (ADC) (41)
Approvals (6336)
Artificial intelligence (107)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4372)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (21)
Brain cancer (16)
Breast cancer (79)
Cancer (615)
Cardiovascular disease (72)
Career advice (408)
Career pathing (12)
CAR-T (22)
Cell therapy (88)
Cervical cancer (4)
Clinical research (30952)
Collaboration (346)
Compensation (155)
Complete response letters (17)
COVID-19 (757)
CRISPR (20)
C-suite (124)
Cystic fibrosis (37)
Data (640)
Denatured (15)
Depression (9)
Diabetes (81)
Diagnostics (1319)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (65)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (32158)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37541)
Executive appointments (392)
FDA (6723)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (215)
Gene editing (38)
Generative AI (9)
Gene therapy (101)
GLP-1 (349)
Government (1300)
Grass and pollen (3)
Guidances (16)
Healthcare (3579)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (14)
Infectious disease (792)
Inflammatory bowel disease (55)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (47)
Interviews (59)
IPO (5880)
IRA (29)
Job creations (2051)
Job search strategy (373)
Kidney cancer (6)
Labor market (12)
Layoffs (180)
Leadership (3)
Legal (3435)
Liver cancer (19)
Lung cancer (82)
Lymphoma (55)
Machine learning (1)
Management (16)
Manufacturing (160)
MASH (32)
Medical device (1280)
Medtech (1282)
Mergers & acquisitions (9674)
Metabolic disorders (262)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (579)
NextGen: Class of 2025 (1586)
Non-profit (594)
Northern California (715)
Now hiring (8)
Obesity (150)
Opinion (119)
Ovarian cancer (21)
Pain (51)
Pancreatic cancer (14)
Parkinson's disease (47)
Partnered (7)
Patents (117)
Patient recruitment (29)
Peanut (10)
People (28967)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8058)
Phase II (13093)
Phase III (11748)
Pipeline (446)
Policy (71)
Postmarket research (1402)
Preclinical (3221)
Press Release (25)
Prostate cancer (46)
Psychedelics (8)
Radiopharmaceuticals (121)
Rare diseases (168)
Real estate (2639)
Recruiting (17)
Regulatory (10129)
Reports (14)
Research institute (566)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (37)
Series B (13)
Service/supplier (3)
Sickle cell disease (32)
Southern California (728)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1630)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (26)
The Weekly (30)
United States (7272)
Vaccines (153)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (3)
Date
Today (49)
Last 7 days (208)
Last 30 days (882)
Last 365 days (11803)
2025 (3642)
2024 (12514)
2023 (14256)
2022 (19564)
2021 (20083)
2020 (19047)
2019 (14904)
2018 (11730)
2017 (13911)
2016 (13135)
2015 (15479)
2014 (12428)
2013 (10599)
2012 (11397)
2011 (11924)
2010 (10891)
Location
Africa (314)
Alabama (13)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (20137)
Australia (2617)
California (1735)
Canada (912)
China (239)
Colorado (70)
Connecticut (68)
Delaware (56)
Europe (39474)
Florida (329)
Georgia (38)
Idaho (9)
Illinois (196)
India (16)
Indiana (135)
Iowa (1)
Japan (93)
Kansas (57)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (258)
Massachusetts (1499)
Michigan (30)
Minnesota (95)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (770)
New Mexico (7)
New York (513)
North Carolina (395)
North Dakota (2)
Northern California (715)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (446)
Puerto Rico (8)
Rhode Island (10)
South America (502)
South Carolina (2)
Southern California (728)
Tennessee (34)
Texas (233)
Utah (33)
Virginia (75)
Washington D.C. (31)
Washington State (120)
Wisconsin (16)
265,952 Results for "jcr pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025
January 28, 2025
·
8 min read
Press Releases
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2025 Showcase Research from Its Investigational Treatments for Lysosomal Storage Disorders
February 5, 2025
·
13 min read
Press Releases
JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy
January 6, 2025
·
5 min read
Business
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
JCR Pharmaceuticals Co., Ltd. announced today that Takeda Pharmaceutical Co., Ltd. (“Takeda”) decided to discontinue their collaboration with JCR to develop gene therapies using adeno-associated viruses (AAV) combined with the JCR J-Brain Cargo ® Technology.
December 21, 2023
·
4 min read
Press Releases
JCR Pharmaceuticals Initiates Phase III Clinical Trial of JR-142 in Japan, a Long-Acting Growth Hormone Therapy
December 23, 2024
·
3 min read
Business
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo ® Technology for Neurodegenerative Disease in Research Collaboration with Alexion.
March 19, 2024
·
4 min read
Genetown
Modalis and JCR Pharmaceuticals enter into joint research agreement
Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) today announced that it has entered into a joint research agreement with JCR Pharmaceuticals Co., Ltd. (JCR Pharmaceuticals) on joint evaluation of the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target.
December 12, 2023
·
2 min read
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
JCR Pharmaceuticals Co., Ltd. announced today that it will present six presentations at the 20th Annual WORLD Symposium ™ 2024, to be held February 4-9, 2024 in San Diego, Calif.
January 25, 2024
·
13 min read
Opinion
Companies Vie to Develop a Hunter Syndrome Therapy That Reaches the Brain
Several companies—including JCR Pharmaceuticals, Denali Therapeutics and Regenxbio—have products in the pipeline that could improve treatment options for this rare disease.
February 3, 2025
·
3 min read
·
Jia Jie Chen
Press Releases
JCR Pharmaceuticals Initiates First Dosing in Phase I Clinical Trial of JR-441 for Mucopolysaccharidosis Type IIIA
October 31, 2024
·
4 min read
1 of 26,596
Next
